SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome, Journal of Clinical Investigation, vol.124, issue.4, pp.1512-1536, 2014. ,
DOI : 10.1172/JCI70921DS1
MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array, Clinical Cancer Research, vol.20, issue.13, pp.3411-3432, 2014. ,
DOI : 10.1158/1078-0432.CCR-13-2173
URL : https://hal.archives-ouvertes.fr/hal-01064619
Estrogen and progesterone receptors as predictive markers for breast cancer and DCIS, 2008. ,
Prognostic and predictive factors in breast cancer by immunohistochemical analysis, Mod Pathol, vol.11, issue.2, pp.155-68, 1998. ,
Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes, Cancer Research, vol.64, issue.3, pp.844-56, 2004. ,
DOI : 10.1158/0008-5472.CAN-03-2361
Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial Neoplasms, The American Journal of Surgical Pathology, vol.26, issue.3, pp.281-91, 2002. ,
DOI : 10.1097/00000478-200203000-00001
Forced Expression of MMP9 Rescues the Loss of Angiogenesis and Abrogates Metastasis of Pancreatic Tumors Triggered by the Absence of Host SPARC, Experimental Biology and Medicine, vol.233, issue.7, pp.860-73, 2008. ,
DOI : 10.3181/0801-RM-12
SPARC: a matricellular regulator of tumorigenesis, Journal of Cell Communication and Signaling, vol.6, issue.180, pp.3-4, 2009. ,
DOI : 10.1007/s12079-009-0072-4
Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer, Clinical Cancer Research, vol.11, issue.10, pp.3714-3735, 2005. ,
DOI : 10.1158/1078-0432.CCR-04-2019
Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast, Virchows Archiv, vol.125, issue.5, pp.532-538, 2005. ,
DOI : 10.1007/s00428-005-1256-9
Tumour microenvironment: TGF??: the molecular Jekyll and Hyde of cancer, Nature Reviews Cancer, vol.274, issue.7, pp.506-526, 2006. ,
DOI : 10.1038/nrc1926
[Angiogenesis and renal cell carcinoma], Bull Cancer, vol.94, pp.232-272, 2007. ,
Invasive growth: a MET-driven genetic programme for cancer and stem cells, Nature Reviews Cancer, vol.16, issue.8, pp.637-682, 2006. ,
DOI : 10.1038/nrc1912
The role of SPARC in extracellular matrix assembly, Journal of Cell Communication and Signaling, vol.54, issue.3-4, pp.3-4, 2009. ,
DOI : 10.1007/s12079-009-0062-6
Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells, Oncogene, vol.21, issue.46, pp.7077-91, 2002. ,
DOI : 10.1038/sj.onc.1205857
URL : https://hal.archives-ouvertes.fr/ensl-00179713
Osteonectin/SPARC is a product of articular chondrocytes/cartilage and is regulated by cytokines and growth factors, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1221, issue.1, pp.7-14, 1994. ,
DOI : 10.1016/0167-4889(94)90209-7
SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2???deoxycytidine to increase SPARC expression and improve therapy response, British Journal of Cancer, vol.159, issue.11, pp.1810-1819, 2008. ,
DOI : 10.1038/sj.onc.1204970
Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis, BMC Cancer, vol.419, issue.2, p.464, 2012. ,
DOI : 10.1016/j.neulet.2007.04.037
SPARC expression induces cell cycle arrest via STAT3 signaling pathway in medulloblastoma cells, Biochemical and Biophysical Research Communications, vol.417, issue.2, pp.874-883, 2012. ,
DOI : 10.1016/j.bbrc.2011.12.065
pT1 clear cell renal cell carcinoma, Cancer, vol.32, issue.8, pp.2180-2184, 2002. ,
DOI : 10.1002/cncr.10433
Neuroblastoma Angiogenesis Is Inhibited with a Folded Synthetic Molecule Corresponding to the Epidermal Growth Factor-Like Module of the Follistatin Domain of SPARC, Cancer Research, vol.64, issue.20, pp.7420-7425, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-2141
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis, Cancer Res, vol.62, issue.24, pp.7357-63, 2002. ,
Sarcomatoid renal cell carcinoma is an example of epithelial-mesenchymal transition, Journal of Clinical Pathology, vol.64, issue.12, pp.1088-92, 2011. ,
DOI : 10.1136/jclinpath-2011-200216
Renal cancer, Critical Reviews in Oncology/Hematology, vol.64, issue.3, pp.247-62, 2007. ,
DOI : 10.1016/j.critrevonc.2007.04.007
Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein, Leukemia, vol.95, issue.3, pp.426-458, 2006. ,
DOI : 10.1002/jcb.240490310
Purification and tissue distribution of a small protein (BM-40) extracted from a basement membrane tumor, European Journal of Biochemistry, vol.23, issue.2, pp.455-64, 1986. ,
DOI : 10.1083/jcb.96.1.124
Pathology and genetics of tumors of the urinary system and male genital organs, IARC, 2004. ,
[Signalling pathways in renal-cell carcinoma: from the molecular biology to the future therapy], Bull Cancer, vol.97, pp.5-15, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00480057
Altered expression of transforming growth factor-??: An early event in renal cell carcinoma development, Molecular Carcinogenesis, vol.35, issue.3, pp.213-222, 1997. ,
DOI : 10.1002/(SICI)1098-2744(199707)19:3<213::AID-MC9>3.0.CO;2-E
Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC, Cancer Research, vol.70, issue.23, pp.9659-70, 2010. ,
DOI : 10.1158/0008-5472.CAN-10-2034
SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival, Oncogene, vol.62, issue.49, pp.4887-900, 2011. ,
DOI : 10.1038/ncb1101-973
The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion, PLoS ONE, vol.12, issue.7, p.40378, 2012. ,
DOI : 10.1371/journal.pone.0040378.s005
URL : https://hal.archives-ouvertes.fr/hal-01068398
The biology of VEGF and its receptors, Nature Medicine, vol.9, issue.6, pp.669-76, 2003. ,
DOI : 10.1038/nm0603-669
SPARC and the Kidney Glomerulus Matricellular Proteins Exhibit Diverse Functions under Normal and Pathological Conditions, Trends in Cardiovascular Medicine, vol.11, issue.1, pp.32-39, 2001. ,
DOI : 10.1016/S1050-1738(01)00081-0
Prognostic significance of morphologic parameters in renal cell carcinoma, The American Journal of Surgical Pathology, vol.6, issue.7, pp.655-63, 1982. ,
DOI : 10.1097/00000478-198210000-00007
A systematic review of predictive and prognostic biomarkers for VEGF-targeted therapy in renal cell carcinoma, Cancer Treatment Reviews, vol.40, issue.4, pp.533-580, 2014. ,
DOI : 10.1016/j.ctrv.2013.11.008
Expression profiling of human renal carcinomas with functional taxonomic analysis, BMC Bioinformatics, vol.3, issue.1, p.26, 2002. ,
DOI : 10.1186/1471-2105-3-26
Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens, The EMBO Journal, vol.17, issue.7, pp.1860-70, 1998. ,
DOI : 10.1093/emboj/17.7.1860
Clear Cell Papillary Renal Cell Carcinoma, The American Journal of Surgical Pathology, vol.32, issue.8, pp.1239-1284, 2008. ,
DOI : 10.1097/PAS.0b013e318164bcbb
HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion, Glia, vol.155, issue.10, pp.1061-75, 2008. ,
DOI : 10.1002/glia.20679
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil???Based Paclitaxel in Women With Breast Cancer, Journal of Clinical Oncology, vol.23, issue.31, pp.7794-803, 2005. ,
DOI : 10.1200/JCO.2005.04.937
Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays, Cancer Res, vol.60, issue.24, pp.6868-74, 2000. ,
Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies, International Journal of Cancer, vol.128, issue.1, pp.101-109, 2005. ,
DOI : 10.1002/ijc.20618
Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study, Laboratory Investigation, vol.7, issue.1, pp.46-56, 2012. ,
DOI : 10.1111/j.1464-410X.2006.06006.x
Highly Sensitive Detection of Melanoma at an Early Stage Based on the Increased Serum Secreted Protein Acidic and Rich in Cysteine and Glypican-3 Levels, Clinical Cancer Research, vol.11, issue.22, pp.8079-88, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-1074
Peritumoral Fibroblast SPARC Expression and Patient Outcome With Resectable Pancreatic Adenocarcinoma, Journal of Clinical Oncology, vol.25, issue.3, pp.319-344, 2007. ,
DOI : 10.1200/JCO.2006.07.8824
Identification of SPARC as a candidate target antigen for immunotherapy of various cancers, International Journal of Cancer, vol.8, issue.6, pp.1393-403, 2010. ,
DOI : 10.1002/ijc.25160
SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration, Journal of Leukocyte Biology, vol.81, issue.3, pp.748-56, 2007. ,
DOI : 10.1189/jlb.1105664
Birt-Hogg-Dub?? syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2, Oncogene, vol.20, issue.37, pp.5239-5281, 2001. ,
DOI : 10.1038/sj.onc.1204703
Prognostic Factors for Renal Cell Carcinoma With Tumor Thrombus Extension, The Journal of Urology, vol.178, issue.4, pp.1189-95, 2007. ,
DOI : 10.1016/j.juro.2007.05.134
The von Hippel???Lindau Tumor Suppressor Gene, Experimental Cell Research, vol.264, issue.1, pp.117-142, 2001. ,
DOI : 10.1006/excr.2000.5139
SPARC: a key player in the pathologies associated with obesity and diabetes, Nature Reviews Endocrinology, vol.10, issue.4, pp.225-260, 2010. ,
DOI : 10.1038/nrendo.2010.18
Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients, Cancer Res, vol.63, issue.17, pp.5376-80, 2003. ,
SPARC (BM-40, Osteonectin) Inhibits the Mitogenic Effect of Vascular Endothelial Growth Factor on Microvascular Endothelial Cells, Journal of Biological Chemistry, vol.273, issue.45, pp.29635-29675, 1998. ,
DOI : 10.1074/jbc.273.45.29635
Novel Function of Alternatively Activated Macrophages: Stabilin-1-Mediated Clearance of SPARC, The Journal of Immunology, vol.176, issue.10, pp.5825-5857, 2006. ,
DOI : 10.4049/jimmunol.176.10.5825
Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape, The Journal of Cell Biology, vol.111, issue.6, pp.3065-76, 1990. ,
DOI : 10.1083/jcb.111.6.3065
The biology of SPARC, a protein that modulates cell-matrix interactions, FASEB J, vol.8, issue.2, pp.163-73, 1994. ,
SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma, The Journal of Pathology, vol.166, issue.4, pp.459-68, 2006. ,
DOI : 10.1002/path.2068
Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells, Nature Medicine, vol.263, issue.2, pp.171-177, 1997. ,
DOI : 10.1016/0167-5699(96)80563-9
The changing pattern of kidney cancer incidence and mortality in Europe, BJU International, vol.353, issue.8, pp.949-58, 2008. ,
DOI : 10.1111/j.1464-410X.2008.07451.x
Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial???mesenchymal transition, Oncogene, vol.10, issue.57, pp.7859-71, 2007. ,
DOI : 10.1038/ncb1173
The Epidemiology of Renal Cell Carcinoma, European Urology, vol.60, issue.4, pp.615-636, 2011. ,
DOI : 10.1016/j.eururo.2011.06.049
Identification of novel VHL target genes and relationship to hypoxic response pathways, Oncogene, vol.2, issue.28, pp.4549-58, 2005. ,
DOI : 10.1038/sj.onc.1208649
Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases, Genes, Chromosomes and Cancer, vol.65, issue.6 ,
DOI : 10.1002/gcc.22248
Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas, Human Pathology, vol.30, issue.3, pp.339-383, 1999. ,
DOI : 10.1016/S0046-8177(99)90014-X
Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma, Journal of Clinical Oncology, vol.23, issue.4, pp.832-873, 2005. ,
DOI : 10.1200/JCO.2005.05.179
Genes that mediate breast cancer metastasis to lung, Nature, vol.436, issue.7050, pp.518-542, 2005. ,
DOI : 10.1038/nature03799
Microscopic venous infiltration as predictor of relapse in renal cell carcinoma, J Urol, vol.148, issue.2, pp.271-275, 1992. ,
Anti-cancer role of SPARC, an inhibitor of adipogenesis, Cancer Treatment Reviews, vol.37, issue.7, pp.559-66, 2011. ,
DOI : 10.1016/j.ctrv.2010.12.001
Collecting System Invasion In Renal Cell Carcinoma: Impact on Prognosis And Future Staging Strategies, The Journal of Urology, vol.170, issue.3, pp.768-72, 2003. ,
DOI : 10.1097/01.ju.0000082580.13597.a2
CD44 IS AN INDEPENDENT PROGNOSTIC FACTOR IN CONVENTIONAL RENAL CELL CARCINOMAS, The Journal of Urology, vol.161, issue.6, pp.1984-1991, 1999. ,
DOI : 10.1016/S0022-5347(05)68869-6
Recommandations en onco-urologie 2013 du CCAFU: Cancer du rein, Progr??s en Urologie, vol.23, issue.2, pp.177-204, 2013. ,
DOI : 10.1016/S1166-7087(13)70055-1
URL : https://hal.archives-ouvertes.fr/hal-01120359
The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host, Cancer and Metastasis Reviews, vol.20, issue.3, pp.691-705, 2008. ,
DOI : 10.1007/s10555-008-9146-7
Distribution of SPARC in normal and neoplastic human tissue., Journal of Histochemistry & Cytochemistry, vol.43, issue.8, pp.791-800, 1995. ,
DOI : 10.1177/43.8.7622842
SPARC Endogenous Level, rather than Fibroblast-Produced SPARC or Stroma Reorganization Induced by SPARC, Is Responsible for Melanoma Cell Growth, Journal of Investigative Dermatology, vol.127, issue.11, pp.2618-2646, 2007. ,
DOI : 10.1038/sj.jid.5700962
The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors., Proceedings of the National Academy of Sciences, vol.89, issue.4, pp.1281-1286, 1992. ,
DOI : 10.1073/pnas.89.4.1281
Projection de l???incidence et de la mortalit?? par cancer urologique en France en 2012, Progr??s en Urologie, vol.23, issue.2, pp.57-65, 2013. ,
DOI : 10.1016/S1166-7087(13)70047-2
Estimation nationale de l'incidence et de la mortalité par cancer en France entre, Institut bational du Cancer, 1980. ,
Gene Expression Profiling and Genetic Markers in Glioblastoma Survival, Cancer Research, vol.65, issue.10, pp.4051-4059, 2005. ,
DOI : 10.1158/0008-5472.CAN-04-3936
Genetics and angiogenesis: the example of von Hippel-Lindau disease], Bull Cancer, vol.94, pp.170-179, 2007. ,
Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma, Urology, vol.55, issue.4, pp.501-506, 2000. ,
DOI : 10.1016/S0090-4295(99)00550-6
The regulatory function of SPARC in vascular biology, Cellular and Molecular Life Sciences, vol.14, issue.1, pp.3165-73, 2011. ,
DOI : 10.1007/s00018-011-0781-8
SPARC Represses E-Cadherin and Induces Mesenchymal Transition during Melanoma Development, Cancer Research, vol.66, issue.15, pp.7516-7539, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-3189
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.322.8079
mTOR and cancer: insights into a complex relationship, Nature Reviews Cancer, vol.10, issue.9, pp.729-763, 2006. ,
DOI : 10.1038/nrc1974
Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture, J Biol Chem, vol.259, issue.6, pp.3993-4007, 1984. ,
Absence of Host-Secreted Protein Acidic and Rich in Cysteine (SPARC) Augments Peritoneal Ovarian Carcinomatosis, The American Journal of Pathology, vol.167, issue.6, pp.1739-52, 2005. ,
DOI : 10.1016/S0002-9440(10)61255-2
Normalization of the Ovarian Cancer Microenvironment by SPARC, Molecular Cancer Research, vol.5, issue.10, pp.1015-1045, 2007. ,
DOI : 10.1158/1541-7786.MCR-07-0001
SPARC expression in primary human renal cell carcinoma: Upregulation of SPARC in sarcomatoid renal carcinoma, Human Pathology, vol.32, issue.10, pp.1064-70, 2001. ,
DOI : 10.1053/hupa.2001.28244
Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays, Cancer Res, vol.63, issue.13, pp.3735-3777, 2003. ,
Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo, Cancer Res, vol.62, issue.21, pp.6270-6277, 2002. ,
Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas, International Journal of Oncology, vol.34, issue.3, pp.707-722, 2009. ,
DOI : 10.3892/ijo_00000197
Regulation of human monocyte matrix metalloproteinases by SPARC, Journal of Cellular Physiology, vol.732, issue.3, pp.327-361, 1997. ,
DOI : 10.1002/(SICI)1097-4652(199712)173:3<327::AID-JCP4>3.0.CO;2-P
Secreted Protein Acidic, Rich in Cysteine (SPARC), Mediates Cellular Survival of Gliomas through AKT Activation, Journal of Biological Chemistry, vol.279, issue.50, pp.52200-52209, 2004. ,
DOI : 10.1074/jbc.M409630200
Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases, Oncogene, vol.159, issue.28, pp.4084-94, 2007. ,
DOI : 10.1038/sj.onc.1210181
Osteonectin downregulates E-cadherin, induces Osteopontin and Focal adhesion kinase activity stimulating an invasive melanoma phenotype, International Journal of Cancer, vol.5, issue.12, pp.2653-60, 2007. ,
DOI : 10.1002/ijc.23039
TNM Classification des tumeurs malignes Septième Edition, 2010. ,
Aberrant Promoter Methylation of Sparc in Ovarian Cancer, Neoplasia, vol.11, issue.2, pp.126-161, 2009. ,
DOI : 10.1593/neo.81146
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia, The American Journal of Surgical Pathology, vol.37, issue.10, pp.1469-89, 2013. ,
DOI : 10.1097/PAS.0b013e318299f2d1
Aberrant methylation of SPARC in human lung cancers, British Journal of Cancer, vol.159, issue.5, pp.942-950, 2005. ,
DOI : 10.1002/cncr.11368
Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy, Molecular Cancer Therapeutics, vol.6, issue.1, pp.309-326, 2007. ,
DOI : 10.1158/1535-7163.MCT-06-0517
Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy, Journal of Clinical Investigation, vol.115, issue.6, pp.1492-502, 2005. ,
DOI : 10.1172/JCI23002
SPARC in cancer biology: Its role in cancer progression and potential for therapy, Drug Resistance Updates, vol.11, issue.6, pp.231-277, 2008. ,
DOI : 10.1016/j.drup.2008.08.005
A Novel Interaction between Procaspase 8 and SPARC Enhances Apoptosis and Potentiates Chemotherapy Sensitivity in Colorectal Cancers, Journal of Biological Chemistry, vol.282, issue.47, pp.34457-67, 2007. ,
DOI : 10.1074/jbc.M704459200
Osteonectin, a bone-specific protein linking mineral to collagen, Cell, vol.26, issue.1, pp.99-105, 1981. ,
DOI : 10.1016/0092-8674(81)90037-4
Prognostic Value of the Involvement of the Urinary Collecting System in Renal Cell Carcinoma, European Urology, vol.46, issue.4, pp.472-478, 2004. ,
DOI : 10.1016/j.eururo.2004.07.006
Epithelial???mesenchymal transitions in tumour progression, Nature Reviews Cancer, vol.59, issue.6, pp.442-54, 2002. ,
DOI : 10.1038/nrc822
Tumour-derived SPARC drives vascular permeability, tumour cell extravasation and metastasis via endothelial VCAM1 signalling, Nature Communications ,
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer, Nature Genetics, vol.30, issue.4, pp.406-416, 2002. ,
DOI : 10.1038/ng849
Interaction of Pax6 with SPARC and p53 in Brain of Mice Indicates Smad3 Dependent Auto-regulation, Journal of Molecular Neuroscience, vol.203, issue.3, pp.397-403, 2010. ,
DOI : 10.1007/s12031-010-9334-0
Immunohistochemical diagnosis of renal neoplasms, Arch Pathol Lab Med, vol.135, issue.1, pp.92-109, 2011. ,
Microscopic Vascular Invasion is the Most Relevant Prognosticator After Radical Nephrectomy for Clinically Nonmetastatic Renal Cell Carcinoma, The Journal of Urology, vol.158, issue.1, pp.45-54, 1997. ,
DOI : 10.1097/00005392-199707000-00013
The phosphatidylinositol 3-Kinase???AKT pathway in human cancer, Nature Reviews Cancer, vol.2, issue.7, pp.489-501, 2002. ,
DOI : 10.1038/nrc839
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine, New England Journal of Medicine, vol.369, issue.18, pp.1691-703, 2013. ,
DOI : 10.1056/NEJMoa1304369
Survey of Differentially Methylated Promoters in Prostate Cancer Cell Lines, Neoplasia, vol.7, issue.8, pp.748-60, 2005. ,
DOI : 10.1593/neo.05289
Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.72, issue.4, pp.267-72, 2005. ,
DOI : 10.1016/j.plefa.2004.12.003
. Comparisons with expression of SPARC (secreted acidic cysteine-rich protein), Biochemical Journal, vol.273, issue.3, pp.523-554, 1991. ,
DOI : 10.1042/bj2730523
Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen, European Journal of Biochemistry, vol.9, issue.2, pp.519-547, 1991. ,
DOI : 10.1016/0168-9525(88)90074-1
Frequent inactivation of SPARC by promoter hypermethylation in colon cancers, International Journal of Cancer, vol.109, issue.3, pp.567-75, 2007. ,
DOI : 10.1002/ijc.22706
SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis in Ovarian Cancer Cells, The American Journal of Pathology, vol.159, issue.2, pp.609-631, 2001. ,
DOI : 10.1016/S0002-9440(10)61732-4